* Sol Gel Technologies Ltd SLGL.OQ reported a quarterly
adjusted
loss of 17 cents per share for the quarter ended in December,
higher than the same quarter last year, when the company
reported EPS of -25 cents. The mean expectation of two analysts
for the quarter was for a loss of 17 cents per share. Wall
Street expected results to range from -19 cents to -16 cents per
share.
* Revenue rose 347% to $447.00 thousand from a year ago;
analysts
expected $267.50 thousand.
* Sol Gel Technologies Ltd's reported EPS for the quarter
was a
loss of 17 cents.
* The company reported a quarterly loss of $4.84 million.
* Sol Gel Technologies Ltd shares had fallen by 4.5% this
quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The average consensus recommendation for the biotechnology
&
medical research peer group is "buy."
Wall Street's median 12-month price target for Sol Gel
Technologies Ltd is $8.00
This summary was machine generated from LSEG data March 13 at
01:31 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 -0.17 -0.17 Met
Sep. 30 2023 -0.23 -0.21 Beat
Jun. 30 2023 -0.25 -0.22 Beat
Mar. 31 2023 -0.21 -0.41 Missed